BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 119419
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.119419
Table 2 Therapeutic targets: Inhibition of neutrophil extracellular traps to ameliorate progression of inflammatory bowel disease
Agent
Target molecule/function
Effect
Disease/animal model
Ref.
Cl-amidinePAD inhibitorInhibit colon inflammation; stimulate apoptosis of inflammatory cells in vitro and in vivoDSS-induced mouse modelChumanevich et al[66]
ButyrateSuppresses neutrophil migration and NETs productionAmeliorate mucosal inflammationDSS-induced murine colitisLi et al[69]
Cyclosporine AInhibit NETs via the regulating PPPReduce ROS-dependent NETs release via downregulating PPP and cellular ROS levels by decreasing G6PD activity directly by activating the P53 proteinDSS-induced colitis mouse modelXu et al[70]
HydroxychloroquineInhibit NET formationHCQ inhibit the activation of MEK/ERK/ROS signaling pathwayDSS induced colitisJiang and Zhang[74]
ThymopentinInhibit NET formationReduced DAI, weight loss and colon shrinkage; decreased MPO, NE, citH3, PAD4, dsDNATNBS-induced colitis mouse modelCao et al[79]
PAD4 genetic deficiencyDown-regulate cGAS-STING pathwayInhibit NET formation, protect the intestinal barrier, alleviate intestinal inflammationDSS-induced colitis miceSun et al[46]
CXCR1 and CXCR2Promote UC and NET formation through neutrophil chemotaxis and PAD4-mediated pathwaysHigher expression of CXCR1/CXCR2 in colon tissues of UC patientsUC; summary data from a genome-wide association study and FinnGenXv et al[71]
Hydrogen sulfideInhibit NET formationInhibit the expression of NF-κB and HMGB1; elevate the expression of anti-inflammatory mediator UCHL-1TNBS-induced colitis rat modelTörök et al[80]


Write to the Help Desk